EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 147 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $406,000 | -17.8% | 7,971 | -10.0% | 0.00% | – |
| Q3 2021 | $494,000 | +37.6% | 8,861 | +5.5% | 0.00% | – |
| Q2 2021 | $359,000 | -12.4% | 8,399 | -14.4% | 0.00% | – |
| Q1 2021 | $410,000 | -8.9% | 9,814 | +1.5% | 0.00% | – |
| Q4 2020 | $450,000 | +1.6% | 9,672 | -7.3% | 0.00% | – |
| Q3 2020 | $443,000 | -13.5% | 10,433 | -2.1% | 0.00% | -100.0% |
| Q2 2020 | $512,000 | +1.8% | 10,661 | -2.4% | 0.00% | 0.0% |
| Q1 2020 | $503,000 | -19.9% | 10,927 | +4.5% | 0.00% | 0.0% |
| Q4 2019 | $628,000 | -0.2% | 10,458 | -6.0% | 0.00% | 0.0% |
| Q3 2019 | $629,000 | +15.0% | 11,127 | +13.2% | 0.00% | 0.0% |
| Q2 2019 | $547,000 | +38.8% | 9,827 | +25.8% | 0.00% | 0.0% |
| Q1 2019 | $394,000 | +53.3% | 7,811 | +22.4% | 0.00% | – |
| Q4 2018 | $257,000 | – | 6,380 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
| TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
| Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
| Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
| Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |